R. Bals et al., THE PEPTIDE ANTIBIOTIC LL-37 HCAP-18 IS EXPRESSED IN EPITHELIA OF THEHUMAN LUNG WHERE IT HAS BROAD ANTIMICROBIAL ACTIVITY AT THE AIRWAY SURFACE/, Proceedings of the National Academy of Sciences of the United Statesof America, 95(16), 1998, pp. 9541-9546
The airway surface is an important host defense against pulmonary infe
ction. Secretion of proteins with antimicrobial activity from epitheli
al cells onto the airway surface represents an important component of
this innate immune system. Defensins are the best characterized epithe
lial-derived peptide antibiotics. A member of another family of peptid
e antibiotics called cathelicidins recently was identified from human
bone marrow. We show in this paper that this human peptide named LL-37
/hCAP-18 also may play a role in innate immunity of the human lung. In
situ hybridization localized high levels of LL-37/hCAP-18 RNA to surf
ace epithelial cells of the conducting airway as well as serous and mu
cous cells of the submucosal glands. LL-37/hCAP-18 peptide with antimi
crobial activity was partially purified from airway surface fluid from
human lung and a human bronchial xenograft model, The synthetic pepti
de LL-37 demonstrated antibiotic activity against a number of Gram-neg
ative and Gram-positive organisms including Pseudomonas aeruginosa; ba
cterial killing of LL-37 was sensitive to NaCl and was synergistic wit
h lactoferrin and lysozyme. In summary, we show that LL-37/hCAP-18 is
a peptide with broad antimicrobial activity that is secreted onto the
airway surface from epithelial cells of the human lung.